
Thalidomide-O-amido-C4-NH2 TFA
CAS No. 1799711-25-3
Thalidomide-O-amido-C4-NH2 TFA( Cereblon Ligand-Linker Conjugates 6 TFA | E3 ligase Ligand-Linker Conjugates 19 TFA )
Catalog No. M28568 CAS No. 1799711-25-3
Thalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 49 | Get Quote |
![]() ![]() |
10MG | 71 | Get Quote |
![]() ![]() |
25MG | 116 | Get Quote |
![]() ![]() |
50MG | 174 | Get Quote |
![]() ![]() |
100MG | 260 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameThalidomide-O-amido-C4-NH2 TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
-
DescriptionThalidomide-O-amido-C4-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate.
-
In Vitro——
-
In Vivo——
-
SynonymsCereblon Ligand-Linker Conjugates 6 TFA | E3 ligase Ligand-Linker Conjugates 19 TFA
-
PathwayOthers
-
TargetOther Targets
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1799711-25-3
-
Formula Weight516.43
-
Molecular FormulaC21H23F3N4O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.86 mg/mL (82.99 mM)
-
SMILESOC(=O)C(F)(F)F.NCCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Hexa-His
Hexa His is an amino acid sequence consisting of 6 His residues in a row, it is also known as hexa histidine-tag, 6xHis-tag, and by the trademarked name His-tag. Hexa His Responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues.
-
Carlinoside
Carlinoside could be a worthy choice to intervene hyperbilirubinemia due to liver dysfunction. Carlinoside upregulates Nrf2 gene expression, increases its nuclear translocation and stimulates UGT1A1 promoter activity.
-
Gelsemine
Gelsemine has marked antinociception in inflammatory, neuropathic and bone cancer pains without inducing antinociceptive tolerance.